ArticleCancer chemotherapy and pharmacology2023

Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.

Kenji Nakahama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.